Can you ask management why other drugs with lesser or earlier stage of trial gets offer while ours seems to be left on the shelf?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025